Skip to main content

Peer Review reports

From: Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD)

Original Submission
8 Nov 2019 Submitted Original manuscript
19 Nov 2019 Author responded Author comments - Phillip Good
Resubmission - Version 2
19 Nov 2019 Submitted Manuscript version 2
Publishing
21 Nov 2019 Editorially accepted
6 Dec 2019 Article published 10.1186/s12904-019-0494-6

You can find further information about peer review here.

Back to article page
\